Top Day Trader Alerts (JASO, GRMN, YRCW, JAZZ, MEDX, BMY, PETD, TOL, XHB, BRCM)

Posted: August 12, 2009 at 9:26 am

These are this morning's top day trader alerts and most active in price and volume. We have more detailed analysis and data on price and volume with links through to ...
Read Full Story »

Media Digest 7/24/2009 Reuters, WSJ, NYTimes, FT. Bloomberg

Posted: July 24, 2009 at 2:54 am

Reuters: Microsoft's (MSFT) results and forecast were weak. Reuters: CIT (CIT) may sell its aviation finance business. Reuters: Fatigue at the Fed is leading to questions about its expanded role. ...
Read Full Story »

Bristol-Myers Gets Key Assets With A Medarex Deal (BMY, MEDX, ABT, JNJ, AMGN, WYE)

Posted: July 23, 2009 at 9:12 am

Bristol Myers Inc. (NYSE: BMY) plans to spend $2.4 billion to buy partner Medarex Inc. (Nasdaq: MEDX). It will get a great deal beyond the cancer monoclonal antibody that developed ...
Read Full Story »

Top Day Trader Alerts (MEDX, ISRG, OREX, CELG, EBAY, SNDK, PSUN, QCOM)

Posted: July 23, 2009 at 7:47 am

The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and ...
Read Full Story »

Media Digest 7/23/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Posted: July 23, 2009 at 2:57 am

Reuters: Obama says healthcare reform is essential to the recovery. Reuters: CIT (CIT) bond advisers will push for Chapter 11. Reuters: Democrats will fight with banks on consumer agency. Reuters: ...
Read Full Story »

Top Analyst Downgrades (ARQL, ASML, CSCO, MEDX, MSFT)

Posted: July 16, 2009 at 7:15 am

These are the top analyst downgrades and cautious research calls we have seen from Wall Street this Thursday morning: ArQule (ARQL) Cut to Sell at UBS. ASML (ASML) Cut to ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Posted: May 27, 2009 at 1:34 pm

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Posted: May 14, 2009 at 4:56 pm

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled ...
Read Full Story »

Medarex Positive Data in Rheumatoid Arthritis Trial (MEDX)

Posted: May 14, 2009 at 7:05 am

Medarex, Inc. (NASDAQ: MEDX) announced that its wholly owned MDX-1100 met its primary endpoints for patients receiving methotrexate in a Phase II 'proof of concept' trial in patients with active ...
Read Full Story »

Weekend of Cancer Data at AACR Ahead of ASCO (ALTH, AMGN, ARIA, ARRY, AZN, BIIB, CELG, CRIS, IMMU, IMGN, INFI, MEDX, MNTA, ONCY, PFE, PCYC, SUPG, TELK, THLD)

Posted: April 17, 2009 at 2:05 pm

This weekend will be a potentially important oncology and cancer news weekend for drug and biotech stocks. The American Association for Cancer Research Meeting will actually have a 100th annual ...
Read Full Story »

MEDX